Respiratory Syncytial Virus
(RSV) Antigen Rapid Test
Rapid chromatographic immunoassay for the direct qualitative identification of Respiratory Syncytial Virus (RSV) viral nucleoproteins in human nasopharyngeal swabs or aspirates. Delivers reliable, visually distinct clinical results in 15 minutes to expedite triage in infants, children, and high-risk elderly populations.
Critical Point-of-Care Differentiation for Pediatric & Geriatric Care
Respiratory Syncytial Virus is the single most common cause of bronchiolitis and lower respiratory infections in infants and elderly adults, presenting symptoms virtually indistinguishable from Influenza or COVID-19.
RSV Subgroups A & B
Features cross-reactive monoclonal antibodies targeting conserved structural proteins, ensuring dependable detection of both Subgroup A and Subgroup B seasonal variants without loss of analytical sensitivity.
- Detects both active viral subgroups
- Calibrated for pediatric mucosal loads
- No false-positive cross-binding
Prevent Unnecessary Antibiotics
Rapid 15-minute diagnosis allows pediatricians and emergency physicians to definitively identify viral etiology, preventing inappropriate antibiotic administration and guiding supportive care immediately.
- Vital in infant bronchiolitis screening
- Reduces pediatric hospital admission stays
- Enables immediate cohorting in PICU / NICU
Room Temperature Stability
Requires no cold-chain storage or specialized refrigeration equipment. Hermetically sealed foil packaging ensures stable 24-month shelf life across clinical settings in Dubai, Abu Dhabi, and the UAE.
- Ambient storage: 2°C to 30°C
- Individually pouched with desiccant
- Supplied with pediatric-friendly flexible swabs
Multi-Center Clinical Evaluation (vs. RT-PCR Reference)
CE-IVD Clinical Trial Cohort (n = 540)| Diagnostic Parameter | Clinical Result | 95% Confidence Interval (CI) | Clinical Significance |
|---|---|---|---|
| Clinical Sensitivity | 93.30% | 87.8% – 96.5% | High diagnostic accuracy in active mucosal viral shedding phase |
| Clinical Specificity | 99.50% | 98.1% – 99.9% | Virtually zero false positives eliminates misdiagnosis and improper cohorting |
| Overall Accuracy | 98.00% | 96.4% – 99.1% | High concordance across pediatric and geriatric clinical sample cohorts |
| Limit of Detection (LoD) | 1.0 x 10³ TCID50/mL | Analytical LoD Protocol | Reliably detects low-titer viral concentrations in nasopharyngeal secretions |
| Cross-Reactivity | 0.0% Non-Reactive | Panel of 22 Respiratory Pathogens | Zero cross-reactivity with SARS-CoV-2, Flu A, Flu B, Adenovirus, or Rhinovirus |
4-Step Standard Operating Procedure
Simple, instrument-free clinical workflow designed for fast execution in outpatient clinics and emergency departments.
Specimen Collection
Collect nasopharyngeal secretions using the sterile flocked pediatric swab or obtain a nasal aspirate specimen from the patient.
Lysis & Extraction
Insert swab into the pre-filled buffer tube. Swirl vigorously 10–15 times while compressing the flexible tube walls against the swab tip.
Sample Inoculation
Secure the dropper nozzle onto the tube. Invert vertically and dispense exactly 3 full drops (80 µL) of extract into sample well (S).
Result Readout
Read chromatographic lines at exactly 15 minutes. Strong positive lines may appear earlier, but negative results must be confirmed at 15 minutes.
Visual Result Interpretation Guide
Rapid, intuitive colorimetric line reading provides unambiguous answers at bedside.
Definitive Test Outcomes
Evaluation of colored bands formed in the reading window:
Clinical Diagnostic Best Practices
Key considerations for healthcare practitioners:
Everything Required for Bedside RSV Testing
Supplied in clinical boxes of 25 tests, fully equipped for point-of-care operation without additional consumables.
Frequently Asked Questions
Need validation dossiers, regulatory certificates, or bulk clinic pricing? Contact our clinical team in Dubai.
Contact Clinical SpecialistDoes this test detect both RSV Subgroup A and Subgroup B?
Yes. The QuRapid RSV Antigen Rapid Test utilizes specific monoclonal antibodies capable of capturing conserved nucleoprotein antigens from both RSV Subgroup A and RSV Subgroup B strains.
Why is rapid point-of-care RSV testing critical in pediatrics?
RSV is the primary cause of acute bronchiolitis and viral pneumonia in infants under 2 years of age. Rapid 15-minute diagnosis enables prompt isolation, prevents inappropriate antibiotic prescriptions, and guides supportive clinical care.
What specimens are validated for the test?
The assay is CE-IVD validated for human nasopharyngeal swab specimens collected with supplied flexible flocked swabs, as well as nasal aspirate and wash fluids.
What is the analytical limit of detection (LoD)?
The analytical limit of detection is 1.0 x 10³ TCID50/mL, providing dependable sensitivity during the peak acute mucosal shedding window.
What are the temperature storage specifications?
Store unopened at 2°C to 30°C. No refrigeration is required, ensuring convenient shelf life of 24 months in clinics, pharmacies, and emergency rooms across the UAE.
Equip Your Clinic With QuRapid RSV Rapid Antigen Tests
Order CE-IVD certified Respiratory Syncytial Virus (RSV) Rapid Test Kits with same-day dispatch across Dubai, Abu Dhabi, and the UAE. Wholesale volume pricing available for pediatric clinics, hospitals, and medical centers.